By
Janssen
Published: Sept. 22, 2014, 8:26 p.m.·
Tags:
Advocacy,
Access,
Drug-resistant TB
Several organizations and individuals working on TB appealed to Janssen to lower bedaquiline's price for all non-high-income countries.
Read More →
By
Janssen
Published: April 29, 2014, 8:55 p.m.·
Tags:
Access,
Public health
New Brunswick, NJ – April 29, 2014 – Johnson & Johnson today announced that its affiliate Janssen Pharmaceutica NV (Janssen) has entered into a novel collaboration with the Stichting International Dispensary Association (IDA), a procurement agent for the Stop TB Partnership’s Global Drug Facility (GDF), to facilitate access to the Company’s anti-tuberculosis medicine. This public-private partnership was established by the newly formed Janssen Global Public Health and is the latest in the Company’s overall efforts to improve public health.
Read More →
By
Janssen
Published: Jan. 23, 2014, 12:33 p.m.·
Tags:
Pharma industry,
Global health,
Access,
Research and development
Janssen Global Public Health to oversee R&D and access strategy development for growing portfolio of transformational medicines
Read More →